{
    "Trade/Device Name(s)": [
        "Lyra RSV + hMPV Assay"
    ],
    "Submitter Information": "Quidel Corporation",
    "510(k) Number": "K230349",
    "Predicate Device Reference 510(k) Number(s)": [
        "K131813"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OEM",
        "OCC"
    ],
    "Summary Letter Date": "February 8, 2023",
    "Summary Letter Received Date": "February 9, 2023",
    "Submission Date": "February 8, 2023",
    "Regulation Number(s)": [
        "21 CFR 866.3980"
    ],
    "Regulation Name(s)": [
        "Respiratory Viral Panel Multiplex Nucleic Acid Assay"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "virology"
    ],
    "Analyte(s)": [
        "Respiratory syncytial virus (RSV)",
        "Human metapneumovirus (hMPV)"
    ],
    "Specimen Type(s)": [
        "Nasal swab",
        "Nasopharyngeal swab"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Life Technologies QuantStudio Dx RT-PCR Instrument",
        "Applied Biosystems 7500 Fast Dx RT-PCR Instrument",
        "Cepheid SmartCycler II System"
    ],
    "Method(s)/Technology(ies)": [
        "Multiplex Real-Time PCR (RT-PCR)",
        "Fluorescent-labeled probe hybridization"
    ],
    "Methodologies": [
        "RT-PCR",
        "Multiplex PCR",
        "Nucleic acid amplification"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Quidel Lyra RSV + hMPV multiplex RT-PCR assay for detection of RSV and hMPV in respiratory swab specimens",
    "Indications for Use Summary": "For qualitative detection and identification of RSV and hMPV RNA in nasal and nasopharyngeal swab specimens from patients with signs and symptoms of respiratory infection, to aid in differential diagnosis in conjunction with clinical and epidemiological factors.",
    "fda_folder": "Microbiology"
}